Clinical Trials Search

Title Intervention NCT IDsort descending Sponsor Status
New Assessment System in Measuring Symptom Distress in Cancer Patients Interview, Quality-of-Life Assessment, Questionnaire Administration NCT00505245 M.D. Anderson Cancer Center Recruiting
Diet and Physical Activity Change or Usual Care in Improving Progression-Free Survival in Patients... Behavioral Dietary Intervention, Compliance Monitoring, Counseling, Educational Intervention, Exercise Intervention, Laboratory Biomarker Analysis, Quality-of-Life Assessment, Questionnaire Administration NCT00719303 Gynecologic Oncology Group Recruiting
CA-IX, p16, Proliferative Markers, and HPV in Diagnosing Cervical Lesions in Patients With Abnormal... Cytology Specimen Collection Procedure, Laboratory Biomarker Analysis NCT00892866 Gynecologic Oncology Group Active, not recruiting
Trial of Acupuncture for Radiation-Induced Xerostomia in Head and Neck Cancer Standard Oral Hygiene, Standard Oral Hygiene + Sham Acupuncture, Standard Oral Hygiene + True Acupuncture NCT01141231 Wake Forest University Health Sciences Active, not recruiting
Vitamin D and Omega-3 Trial (VITAL) vitamin D3, omega-3 fatty acids (fish oil), Vitamin D3 placebo, Fish oil placebo NCT01169259 Brigham and Women's Hospital Active, not recruiting
Relaxation for Women With Breast Cancer Undergoing Radiotherapy Relaxation Program, Questionnaires, Saliva Testing NCT01202851 M.D. Anderson Cancer Center Active, not recruiting
Controlled Trial Of Acupuncture To Prevent Radiation-Induced Xerostomia Acupuncture - Group 1, Acupuncture - Group 2, Standard Care, Questionnaire NCT01266044 M.D. Anderson Cancer Center Active, not recruiting
Trial of Individual Psychosocial Interventions for Cancer Patients Individual Meaning-Centered Psychotherapy (IMCP), standard Individual Supportive Psychotherapy (ISP), enhanced usual care (EUC) NCT01323309 Memorial Sloan Kettering Cancer Center Active, not recruiting
S0820, Adenoma and Second Primary Prevention Trial Eflornithine placebo & sulindac, Eflornithine placebo & sulindac placebo, Eflornithine plus sulindac, eflornithine & sulindac placebo NCT01349881 Southwest Oncology Group Recruiting
Assessment of Cognitive Function in Breast Cancer and Lymphoma Patients Receiving Chemotherapy NCT01382082 University of Rochester NCORP Research Base Enrolling by invitation

Pages